Abiomed’s Impella Now Linked to 4 Deaths in Recent Recall

Adding another layer to Abiomed’s challenging last few months connected to its Impella heart pumps, FDA has updated the device’s Class I recall regarding a potential conflict in patients with transcatheter aortic valve replacements (TAVR), adding that four deaths have now been linked to the issue.